Luteal Phase Defect: What It Is, How It Is Diagnosed and What Helps

Luteal Phase Defect: What It Is and What to Do

The luteal phase is the second half of the menstrual cycle — from ovulation to the next period. After ovulation, the ruptured follicle becomes the corpus luteum and produces progesterone, which prepares the uterine lining for implantation. Luteal phase defect (LPD) occurs when this progesterone support is insufficient.

What Is Luteal Phase Defect?

LPD is broadly defined as inadequate progesterone production during the luteal phase. This can manifest as:

• Insufficient progesterone levels — the corpus luteum doesn't produce enough
• Shortened luteal phase — the corpus luteum fails earlier than normal (less than 11 days between ovulation and next period)
• Both simultaneously

The result: inadequate endometrial preparation for implantation, or failure to maintain an early implanted embryo.

How Common Is LPD?

LPD is controversial — its clinical significance and prevalence are debated. It affects:

• Approximately 5–8% of apparently normal cycles in fertile women
• Up to 25–35% of cycles in infertile women (particularly those with PCOS, thyroid dysfunction, or hyperprolactinaemia)
• Very common in cycles stimulated with clomiphene or FSH for ovulation induction

Causes

Underlying hormonal conditions:

• Hypothyroidism — one of the most important and most treatable. Suboptimal thyroid function directly impairs corpus luteum function and progesterone production. TSH >2.5 mIU/L is associated with LPD.
• Hyperprolactinaemia — elevated prolactin disrupts the corpus luteum
• PCOS — disordered LH pulsatility impairs corpus luteum development

Ovulation induction: Clomiphene and FSH can cause LPD in stimulated cycles — the pharmacologically-induced ovulation does not always result in an optimal corpus luteum. This is why progesterone supplementation is standard in IUI and IVF cycles.

Age-related: Corpus luteum function declines with age — LPD is more common in women over 40.

How It Is Diagnosed

LPD diagnosis is inconsistent and debated. Methods:

Mid-luteal serum progesterone: Measured approximately 7 days after ovulation (Day 21 in a 28-day cycle; or 7 days before expected next period in irregular cycles).

• >10 ng/mL: Normal luteal function
• 3–10 ng/mL: Low-normal — may indicate LPD
• <3 ng/mL: Confirms ovulation occurred but suggests poor corpus luteum function

Limitation: Progesterone is secreted in pulses — a single measurement can miss trough levels. Serial measurements (every 48 hours) give a better picture. No universally agreed cut-off for diagnosis.

Endometrial biopsy (historical — rarely used now): Previously used to look for "dating discordance" (endometrium appearing less developed than expected for cycle day). Largely abandoned — poor reproducibility and correlation with fertility outcomes.

Luteal phase length: A luteal phase consistently shorter than 11 days (confirmed by BBT charting + OPK) is a clinical marker of LPD.

Does Luteal Phase Defect Cause Infertility?

The evidence is mixed. LPD is more common in infertile women, but:

• Ovulation induction cycles (which almost always cause some degree of LPD) succeed despite this when progesterone supplementation is given
• There is no RCT proving that progesterone treatment for natural cycle LPD improves live birth rates

Current consensus (ASRM 2023): LPD is likely a real phenomenon that can impair fertility, but the evidence base for treatment in natural cycles is weaker than for supplemented IVF/IUI cycles.

Treatment

Progesterone supplementation:

• Vaginal progesterone pessaries (Cyclogest 400mg, Crinone 8%) — given from approximately 3 days after ovulation
• Used routinely in all IVF and IUI cycles — standard of care
• For natural cycle LPD: reasonable to use; ESHRE supports progesterone in unexplained RPL and early pregnancy bleeding

Treat underlying cause:

• Hypothyroidism: Levothyroxine to achieve TSH <2.5 mIU/L — often restores normal luteal function without specific progesterone supplementation
• Hyperprolactinaemia: Cabergoline — directly improves corpus luteum function
• PCOS: Letrozole-induced ovulation + progesterone support

hCG injections (historical): hCG mimics LH and can support the corpus luteum. Used in some protocols but largely replaced by direct progesterone supplementation.

Reference: ASRM Practice Committee — Luteal Phase Deficiency, 2021. ESHRE — Recurrent Pregnancy Loss, 2023.